The Albert Einstein College of Medicine of Yeshiva University is a premiere, research medical school dedicated to biomedical investigative studies and procurement of ethical and compassionate scientists and physicians. Inspired by their namesake, the university “welcomes students, faculty, and staff from diverse backgrounds who strive to enhance human health in the community and beyond.” Education is the heart of Einstein’s undertaking although they are a leader in biomedical research. During 2012, Einstein faculty received nearly $160 million in funding from the National Institutes of Health.
Karen and David Mandelbaum and Albert Einstein College of Medicine of Yeshiva University invite members to a join in the discussion “Look to the Future: A Conversation on Vital Areas of Medical Research Affecting Us, Our Children, and Our Grandchildren”, scheduled for Wednesday, March 20, 2013 – 4:30pm to 6:30pm in the Harbourview Room at The Club at Admirals Cove, Jupiter, Florida.
Allen M. Spiegel, M.D. will moderate the discussion and address questions on Alzheimer’s disease, stem cell research, and personalized medicine approaches to cancer and other diseases. Dr. Spiegel is Dean of the Albert Einstein College of Medicine and an internationally recognized researcher and endocrinologist. Dr. Spiegel earned his bachelor’s degree summa cum laude from Columbia University in 1967, his M.D. degree cum laude from Harvard Medical School in 1971, and completed his medical training at Massachusetts General.
Judy Aschner, M.D. is the University Chair at Albert Einstein College of Medicine and Physician-In-Chief at the Children’s Hospital of Montefiore. Dr. Aschner completed her medical training, including pediatric residency and neonatology fellowship, at the University of Rochester School of Medicine. Dr. Aschner’s research focus is neonatal pulmonary hypertension in full term and preterm infants with lung and heart disease. Dr. Aschner will discuss and address questions about new therapies for neonatal pulmonary hypertension, preterm birth and chronic lung disease of prematurity, and the vital role of research in improving pregnancy outcomes and child health.
Michael Aschner, Ph.D, is one of the leading neurobiologists studying the effects of heavy metals on the brain. Dr. Aschner is Professor of Molecular Pharmacology and of Pediatrics, and director of a new Einstein center of toxicology. Dr. Spiegel is quoted as saying “Michael Aschner is an outstanding scientist who will bring an important new dimension to Einstein’s research portfolio.” Dr. Aschner will discuss and respond to questions on the impact of heavy metals on brain development, the interaction between genes and the environment in triggering brain disease, and how heavy metals may lead to Parkinson’s.
This is a rare opportunity to hear such distinguished guest speakers in our Jupiter community. Reservations are required to attend. Please call 561-745-5902 to reserve your seat.